Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome-Reference-Cited by-同舟云学术

Clinical and genetic predictors of atypical hemolytic uremic syndrome phenotype and outcome

Published:2018-08 Issue:2 Volume:94 Page:408-418
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Schaefer Franz,Ardissino Gianluigi,Ariceta Gema,Fakhouri Fadi,Scully Marie,Isbel Nicole,Lommelé Åsa,Kupelian Varant,Gasteyger Christoph,Greenbaum Larry A.,Johnson Sally,Ogawa Masayo,Licht Christoph,Vande Walle Johan,Frémeaux-Bacchi Véronique,Blasco Miquel,Cresseri Donata,Generolova Galina,Webb Nicholas,Hirt-Minkowski Patricia,Lvovna Kozlovskaya Natalya,Landau Danny,Lapeyraque Anne-Laure,Loirat Chantal,Mache Christoph,Malina Michal,Martola Leena,Massart Annick,Rondeau Eric,Siedlecki Andrew,Sartz Lisa

Publisher

Elsevier BV

Subject

Nephrology

Reference25 articles.

1. Atypical hemolytic-uremic syndrome;Noris;N Engl J Med,2009

2. Syndromes of thrombotic microangiopathy;George;N Engl J Med,2014

3. An international consensus approach to the management of atypical hemolytic uremic syndrome in children;Loirat;Pediatr Nephrol,2016

4. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference;Goodship;Kidney Int,2017

5. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults;Fremeaux-Bacchi;Clin J Am Soc Nephrol,2013

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Outcomes of Anticomplement Factor H Antibody Positive Versus Negative Atypical Hemolytic Uremic Syndrome;Indian Journal of Nephrology;2024-08-14

2. Annual trends in atypical haemolytic uremic syndrome management in Japan and factors influencing early diagnosis and treatment: a retrospective study;Scientific Reports;2024-08-06

3. Thrombotic Microangiopathy in Pregnancy: Current Understanding and Management Strategies;Kidney International Reports;2024-08

4. Ex vivo C5b-9 Deposition Test to Monitor Complement Activity in Clinical and Subclinical Atypical Hemolytic Uremic Syndrome and in Transplantation-Associated Thrombotic Microangiopathy;Kidney International Reports;2024-07

5. Recurrent complement-mediated Hemolytic uremic syndrome after kidney transplantation;Transplantation Reviews;2024-07